Our company is a professional company dealing in chemical APIs and intermediates, including R & D, production, import and export. The company has established long-term technical cooperation with Tsinghua University, Hebei University of science and technology and other institutions to improve the technology of existing products, reduce costs, improve quality and ensure that the technical level of the company is at the advanced level at home and abroad. At the same time, it continuously carries out research and development of new products to promote the sustainable development of the enterprise. Our company also makes great efforts to develop import and export business, and provides many pharmaceutical factories at home and abroad with products with lower cost, better quality and more comprehensive varieties.

Active pharmaceutical ingredient (API), usually referred to as chemical API, is an effective component in chemical pharmaceutical preparations. Driven by multiple factors, such as population growth and aging, the cliff of international patented drugs, the transfer of global API production capacity, and the increase of drug penetration through volume procurement, the upstream of chemical APIs as chemical agents has achieved sustained growth, but it is also facing development bottlenecks, such as the increasing pressure on environmental protection and the improvement of technical barriers.

China is the world's largest producer and exporter of bulk drugs. The chemical bulk drug industry has developed rapidly, and has continued to improve in terms of industrial scale, production technology and quality. At the same time, it is also at the stage of transformation and upgrading to adjust the industrial structure, improve the industrial layout and improve the level of green production, so as to accelerate the pace of high-quality industrial development.